Teaser for report - Drug Research Scenario in India

…………. Realizing Possibilities
Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 1
Research Report on Drug Research Scenario in India
INTRODUCTION
Common perception about Indian Pharma companies is that they are good in
generics and that drug research activities are less in India.
Contrarian to popular belief, it was in the late 1990’s, that Indian Pharma
companies started in-house drug discovery activities, aiming at developing the
country’s first home-made drug.
Today, there are many Indian companies involved in drug discovery, research and
allied services. Even Government is lending help and supporting research activities
in a big way through IP Protection laws and Public Private Partnerships in this space.
New Drug Discovery and allied services has gained strong foothold in India.
India is today one of the most sought after destinations for
collaboration in Drug Research
The research report of Aagami - ‘Drug
Research Scenario in India’ – reveals how
and what Indian companies are doing in the
area of drug research and details out which
companies are most active in the area of drug
discovery, research activities and allied services
A must read for global companies who wish to
collaborate with Indian companies

Research Scope and Structure
 The Indian Pharma market
prior to introduction of
Patents Act of 1970
 Presence of Multinational
companies
 Introduction of Patents Act
of 1970
 Impact of TRIPS w.e.f
January 1995
 Top Indian Pharma companies
expenditure on R&D.
 Deals: Partnering of MNCs
with Indian companies for
Collaborative research, R&D
service agreement
 Paradigm shift
 India as destination for
conducting clinical trials
 MNC CRO in India
 Indian companies has moved
up value chain
 Major therapeutic areas for
drug research
 Key therapy area for NCE of
top Indian pharma
companies
 Therapeutic segment sales
as of March 2012
 Biosimilars
 Major Platform
considered/focused for
NDDS
 Repurposing/Re-profiling of
Drugs
 India’s IP regime
 Public Private Partnership as
a Indian Government
initiatives
 Benefits of Collaboration
 Conclusion
Overview: Historical perspective
of Indain Pharma Market Current status in Drug
Research
Trends in Drug
Discovery
Government
Initiatives
Conclusion

Table of Contents:
1. Introduction
a. Objective of white paper
b. Executive Summary
2. Acronyms Used
3. Overview: Historical perspective of Indian Pharma market
a. Key Takeaway in Indian Pharma sector before and after enactment of Patents Act 1970
b. Table for three phases in Indian Pharmaceuticals.
c. Impact of TRIPS on Indian Pharmaceutical companies
4. Scenario in India after 1970 patent Law which recognized process patents
a. Example of Importance of India as the “Pharmacy for the developing world
5. Impact of World Trade Organization’s Trade Related Aspects of Intellectual Property Rights (TRIPs) agreement on India
6. Current Status: In-Licensing & Out Licensing Deal (2002- 2011)
a. Table for India’s top Pharmaceuticals company by sales and R&D expenditure
b. Key examples of Drug research collaboration
c. Table for R&D Out-Licensing deal.
d. Table for Collaborative R&D agreement
e. Table for Collaborative research done in India
f. Table for Out-Licensing in India with global partners
Contract Research (2006-2011)
g. Table for R&D service agreement by Indian companies with MNC partner
Mergers & Acquisitions (2004- 2012)
h. Other R&D deal.
i. Matrix for type of Alliances in India
j. Top 10 Bioscience collaboration in 2012 for Drug research & allied services
k. Paradigm Shift
7. Drug Portfolio pipeline of top Indian Pharma companies
8. Examples of Indian companies offering Drug Research services
9. India- hottest and favored destination for Clinical research outsourcing & conducting global trials in BRIC region
10. List of MNC having their Drug Discovery and service centers in India

11. Instances for Indian companies have moved up the value curve
12. Trends in Drug Research in India
a. Top key therapy areas in focus
b. Table for Company & therapy areas
c. Therapeutic segment sales as of March 2011
d. Biosimilars in India
e. Top pharma companies & their biosimilar portfolio
f. NDDS
g. NDDS success stories & Market segment
h. Repurposing of Drugs in India
i. Initiatives for Repurposing of Drugs
13. India’s IP regimes & Government Initiatives
14. Benefits Of Collaborations
15. Conclusion
Rest of Page is blank. SEE NEXT PAGE

Key Highlights of the report:
1. The report gives whole scenario of Drug Research activities being carried out in India
2. Current market scenario in India
3. Top Indian Pharma companies with sales and R&D expenditures
4. Information on M&A, Joint research, CRO deals , In-Licensing, Out- Licensing deals took place
5. Top Indian Pharma companies with Drug Portfolios, patent pipeline, NCE pipelines
6. List of Indian companies offering Drug research services (CRO)and their operation and services portfolio
7. List of MNC CRO operating in India with their operation and services portfolio
8. India as a global destination for conducting global clinical trials & clinical outsourcing
9. Types of Alliances in India with MNCs.
10. India’s Top 10 Bioscience collaboration in 2012 indicating India’s expertise in Drug research arena.
11. Trends in Drug Research
12. Government Initiatives & India IP regime
13. Benefits of Collaborations
14. Facts and figures on India’s advantage for Drug research as compared to developed countries

A Must Buy for:
1. Foreign companies who wish to collaborate with Indian companies
2. Existing Pharma/Biotech/ Drug Discovery Firms: To know their Indian counterpart Drug Development pipeline, trends,
Information on leading pharma companies by sales & their R&D expenses.
3. New Pharma/Biotech/ Drug Discovery Firms: Information on In-Licensing & Out- Licensing scenario. Information on existing
& new players in Drug Discovery
4. Research & Educational Institutes: To get an overview of India’s pharma & drug discovery scenario and current trends in
Drug R&D
5. Consultants: To upgrade their knowledge in Indian pharma and drug R&D space.
6.

Sample Snapshots of the Report:
The Snapshots provided hereby is just a sneak peak of
the whole report.
The original document comprise of 45 slides. The
report gives a complete scenario about the research
activities being carried out in India.
India has proven conducive environment,
infrastructure to carry out their drug research work
and as well assist global pharmaceuticals and biotech
firms in their research activities.

The Snapshots provided hereby is just a sneak peak
of the whole report.
The original document comprise of 45slides. The
report gives a complete scenario about the research
activities being carried out in India.
India has proven conducive environment,
infrastructure to carry out their drug research work
and as well assist global pharmaceuticals and
biotech firms in their research activities.

Contact us at godwyn@aagami.com or
nidhi@aagami.com to have complete access
to the full details of the report

To place an order for this report, please get in touch with:
Godwyn Francis - Business Development, Aagami, Inc.
Email Id: godwyn@aagami.com
Contact number: +91- 787-5106- 957
Aagami Inc,
2020 Calamos Court, Suite 209,
Naperville IL 60563-2593
www.aagami.net
The Snapshots provided in previous pages, is just a sneak peak of the whole report.
The original document consists of 45 pages. The report gives a complete scenario about the research activities being carried out in
India.
India has proven conducive environment, infrastructure to carry out their drug research work and as well assist global
pharmaceuticals and biotech firms in their research activities.

Teaser for report - Drug Research Scenario in India

Recomendados

Recomendados

Mais conteúdo relacionado

Destaque

Destaque (6)

Mais de Aagami, Inc.

Mais de Aagami, Inc. (20)

Último

Último (20)

Teaser for report - Drug Research Scenario in India